Social
Protective Effects of Colchicine in Non-Hospitalized COVID-19
A press release from the Montreal Heart Institute has announced that the COLCORONA clinical trial has provided evidence of the protective effect of colchicine.
Read more:
https://t.co/xW5SchMUeK https://t.co/tUoDTJKbVG
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
How risky are family gatherings, birthday parties and informal social gatherings?
Read more…
https://t.co/jyGHakndUt https://t.co/7eps0EFVWy
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
CDC: as of 5/15/2021; the rates of flu test positivity was 0.051-0.18% for the 2020-21 flu season - compared to usual rate of 10%-19% before COVID. Actual influenza hospitalizations dropped from 44.2 to 0.8/100 000 population https://t.co/N8b1sQWWIh
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
FDA has granted emergency use authorization (EUA) for Actemra (tocilizumab) us in treating hospitalized COVID-19 (adults and kids) patients on steroids and who require, supplemental oxygen, mechanical ventilation, or ECMO https://t.co/YAVfbykcti https://t.co/d7pS1lUXpa
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
Italian survey foud 82% of MSK healthcare workers willing to receive COVID-19 vaccine, but only 55% of their rheumatic Dz patients were as willing, even if they perceived they were at risk. Not out of fear or distrust. more education needed https://t.co/nPhhME2dnC
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheums’ offices everywhere this year, and at #EULAR2021, data presented from Israel, has provided much-needed answers.
https://t.co/PUa6deflTy https://t.co/cs4MwnIcdR
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 10 months ago
Mavrilimumab (GM-CSFi) phase II trial of COVID-19 PNA and systemic hyperinflammation
⭐️65% risk reduction in ventilation/death
⭐️no sig difference in ventilation requirement
⭐️no serious AE
Abs#LB0001
#EULAR2021 @RheumNow
Robert B Chao, MD @doctorRBC ( View Tweet )
2 years 10 months ago
This is by far the biggest rheum dx COVID vaccinated cohort described I'm aware of 👏
Looking forward to full paper, & we will need data with more pts, more details, cellular response etc.
Nevertheless, invaluable & reassuring.
So glad to see it at #EULAR2021 LB0003 @RheumNow https://t.co/jsHZjLdCTT
David Liew @drdavidliew ( View Tweet )
2 years 10 months ago
6. Rheum disease activity was stable with COVID vaccination.
(RA, PsA, axSpA, SLE - total n = 597)
7/
LB0003 #EULAR2021 @RheumNow https://t.co/xxkrunjPa0
David Liew @drdavidliew ( View Tweet )
2 years 10 months ago
Israel was early to COVID vaccinate on mass scale. How well did the vaccine work in their rheum dx pts?
rheum pts n=686 (vs controls n = 121)
- fewer w immunogencity, but not bad (86% vs 100%)
- safety good
- dx activity stable
more details below ⬇️
LB0003 #EULAR2021 @RheumNow https://t.co/h2WT404mkF
David Liew @drdavidliew ( View Tweet )
2 years 10 months ago
